首页 > 市场调查报告书 > 医疗设备

体外诊断

C反应蛋白检测市场规模、份额和成长分析（按检测类型、检测范围、疾病领域、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1898570

C反应蛋白检测市场规模、份额和成长分析（按检测类型、检测范围、疾病领域、最终用途和地区划分）－2026-2033年产业预测

C-reactive Protein Testing Market Size, Share, and Growth Analysis, By Assay Type (Immunoturbidimetric Assay, Elisa), By Detection Range (HS-CRP, Conventional CRP), By Disease Area, By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，C 反应蛋白检测市场规模将达到 31.9353 亿美元，从 2025 年的 32.7017 亿美元成长到 2033 年的 39.534 亿美元，在预测期（2026-2033 年）内复合年增长率为 2.4%。

由于奈米技术的进步提高了现场疾病诊断的特异性、灵敏度和速度，C反应蛋白（CRP）检测市场正经历显着成长。新开发的就地检验有望透过实现快速CRP检测来推动市场需求成长。发炎性疾病、糖尿病和癌症发生率的上升，以及女性子宫内膜异位症等疾病盛行率的增加，也推动了这一趋势。此外，诊断领域的投资增加和照护现场设备的日益普及预计也将促进市场扩张。随着医疗保健系统寻求高效的诊断工具，CRP检测市场有望实现强劲成长，因为它满足了早期发现和监测各种健康状况的需求。

C反应蛋白检测市场驱动因素

全球C反应蛋白检测市场预计将迎来显着成长，主要驱动因素是心血管疾病盛行率的不断上升以及旨在改进检测方法的研究和开发投入的活性化。心血管疾病死亡率的惊人统计数据凸显了这些疾病造成的大量死亡所带来的严峻医疗保健挑战。这种紧迫性凸显了对精准诊断工具的需求，从而推动了对创新C反应蛋白检测解决方案的进一步关注和投资。随着医疗保健提供者和研究人员不断认识到早期发现和监测与心臟疾病相关的发炎过程的重要性，对更先进检测能力的需求预计将显着增加。

限制C反应蛋白检测市场的因素

全球C反应蛋白检测市场的成长可能受到几个关键因素的阻碍。主要因素是人们对C反应蛋白检测的认知度较低，这可能会阻碍其普及和应用，尤其是在缺乏先进技术的中小经济体中。此外，这些检测方法的高成本，以及购买设备所需的大量初始投资，预计也将对市场扩张构成额外障碍。因此，这些挑战可能会显着限制C反应蛋白检测市场在各地区的潜在发展。

C反应蛋白检测市场趋势

受以预防和管理慢性疾病为重点的宣传活动日益增多的推动，C反应蛋白（CRP）检测市场正呈现显着的成长趋势。政府主导的各项措施在提升CRP检测的重要性方面发挥关键作用，尤其是在已开发国家，这些措施促进了CRP检测在常规临床实践中的应用。 CRP检测应用的持续普及证实了其在诊断和后续观察发炎性疾病方面的价值，有助于改善患者的治疗效果。随着医疗服务提供者、患者和政策制定者逐渐认识到CRP检测在预防性医疗保健管理中的重要性，该市场有望迎来强劲增长，并重塑全球诊断服务格局。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Thermo Fisher Scientific Inc.
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Siemens Healthcare
Quest Diagnostics
Ortho Clinical Diagnostics
Randox Laboratories
Boditech Med Inc.
Merck Millipore
BioMerieux
Trinity Biotech
Becton, Dickinson and Company（BD）
Sekisui Diagnostics
Tosoh Bioscience Inc.
DiaSorin SpA
Fujifilm Corporation

结论与建议

简介目录

Product Code: SQMIG35A2715

C-reactive Protein Testing Market size was valued at USD 3193.53 Million in 2024 and is poised to grow from USD 3270.17 Million in 2025 to USD 3953.4 Million by 2033, growing at a CAGR of 2.4% during the forecast period (2026-2033).

The market for C-reactive protein (CRP) testing is experiencing significant growth driven by advancements in nanotechnology that enhance specificity, sensitivity, and speed for on-site disease diagnostics. Newly developed point-of-care assays are expected to boost demand as they enable rapid CRP testing. The rising incidence of inflammatory conditions, diabetes, and cancers further contributes to this trend, with an increasing prevalence of diseases like endometriosis among women. Additionally, heightened funding in the diagnostics sector and the growing adoption of point-of-care devices are anticipated to accelerate market expansion. As healthcare systems seek efficient and effective diagnostic tools, the CRP testing market is poised for robust growth, responding to the need for early detection and monitoring of various health conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the C-reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

C-reactive Protein Testing Market Segments Analysis

Global C-Reactive Protein Testing Market is segmented by assay type, detection range, disease area, end-use and region. Based on assay type, the market is segmented into immunoturbidimetric assay, ELISA, chemiluminescence immunoassay and others. Based on detection range, the market is segmented into HS-CRP, conventional CRP and cCRP. Based on disease area, the market is segmented into cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus and others. Based on end-use, the market is segmented into clinics, hospitals, laboratories, assisted living healthcare facilities, home and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the C-reactive Protein Testing Market

The global C-reactive protein testing market is poised for significant growth, primarily driven by the escalating prevalence of cardiovascular diseases and an upsurge in research and development efforts aimed at improving testing methodologies. The alarming statistics surrounding cardiovascular mortality highlight a critical healthcare concern, with numerous fatalities attributed to these conditions. This urgency underscores the need for accurate diagnostic tools, further fueling interest and investment in innovative C-reactive protein testing solutions. As healthcare providers and researchers continue to recognize the importance of early detection and monitoring of inflammatory processes related to heart disease, the demand for enhanced testing capabilities is expected to increase substantially.

Restraints in the C-reactive Protein Testing Market

The growth of the global C-reactive protein testing market is likely to be hindered by several significant factors. Chief among these is the limited awareness surrounding CRP testing, which could impede adoption and utilization, especially in low-to-medium-sized economies where access to advanced technologies is lacking. Furthermore, the prohibitive costs associated with these testing methods, coupled with the substantial initial investments needed for equipment setup, are expected to create additional barriers to market expansion. As a result, these challenges may significantly restrict the potential development of the C-reactive protein testing market in various regions.

Market Trends of the C-reactive Protein Testing Market

The C-reactive protein (CRP) testing market is witnessing a significant upward trend driven by heightened awareness campaigns focused on the prevention and management of chronic disorders. Government initiatives are playing a pivotal role in promoting the importance of CRP testing, consequently boosting its incorporation into routine clinical practices, particularly in developed countries. This increased adoption underscores the testing's value in diagnosing and monitoring inflammatory conditions, enhancing patient outcomes. As healthcare providers, patients, and policymakers recognize the critical role of CRP testing in proactive health management, the market is poised for robust growth, reshaping the landscape of diagnostic services globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global C-Reactive Protein Testing Market Size by Assay Type & CAGR (2026-2033)

Market Overview
Immunoturbidimetric Assay
Elisa
- Clinical
- Non-Clinical
Chemiluminescence Immunoassay
Others

Global C-Reactive Protein Testing Market Size by Detection Range & CAGR (2026-2033)

Market Overview
HS-CRP
Conventional CRP
CCRP

Global C-Reactive Protein Testing Market Size by Disease Area & CAGR (2026-2033)

Market Overview
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others

Global C-Reactive Protein Testing Market Size by End-Use & CAGR (2026-2033)

Market Overview
Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
Hospitals
- Urban Setting
- Rural Setting
Laboratories
- Urban Setting
- Rural Setting
Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
Home
Others

Global C-Reactive Protein Testing Market Size & CAGR (2026-2033)

North America (Assay Type, Detection Range, Disease Area, End-Use)
- US
- Canada
Europe (Assay Type, Detection Range, Disease Area, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Assay Type, Detection Range, Disease Area, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Assay Type, Detection Range, Disease Area, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Assay Type, Detection Range, Disease Area, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boditech Med Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Millipore
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tosoh Bioscience Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments